Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit

Table 1

The prevalence of MDR bacteria in our study population.

Class of MDR bacteria	Prevalence, n (%)
Acinetobacter	37 (41.1%)
Pseudomonas aeruginosa	12 (13.33%)
Stenotrophomonas maltophilia	5 (5.56%)
Enterococci	7 (7.78%)
Enterobacteria	9 (10%)
Overall MDR bacteria prevalence	43 (47.78%)
MDR: multi drug resistant; n: number of subjects